{"nct_id":"NCT02819999","title":"A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer","status":"TERMINATED","status_verified_date":"2019-06","start_date":"2016-10","start_date_type":null,"primary_completion_date":"2019-05-31","primary_completion_date_type":"ACTUAL","completion_date":"2019-05-31","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}